LC
LLY icon

Lavaca Capital’s Eli Lilly LLY Stock Holding History

Lavaca Capital’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$583K Buy
486
+100
+26% +$102K 0.06% 74
2026
Q1 		$355K Hold
386
– – 0.06% 81
2025
Q4 		$415K Sell
386
-1
-0.3% -$956 0.07% 70
2025
Q3 		$295K Sell
387
-916
-70% -$682K 0.05% 84
2025
Q2 		$1.02M Buy
1,303
+101
+8% +$78.5K 0.38% 38
2025
Q1 		$993K Sell
1,202
-53
-4% -$44.1K 0.41% 40
2024
Q4 		$969K Buy
1,255
+55
+5% +$45.5K 0.38% 42
2024
Q3 		$1.06M Buy
1,200
+1
+0.1% +$899 0.45% 39
2024
Q2 		$1.09M Buy
1,199
+1
+0.1% +$800 0.56% 27
2024
Q1 		$932K Sell
1,198
-1,754
-59% -$1.25M 0.54% 32
2023
Q4 		$1.72M Sell
2,952
-58
-2% -$33.9K 0.98% 17
2023
Q3 		$1.62M Sell
3,010
-164
-5% -$84.5K 0.54% 35
2023
Q2 		$1.49M Sell
3,174
-84
-3% -$35.2K 0.44% 45
2023
Q1 		$1.12M Sell
3,258
-97
-3% -$32.7K 0.23% 68
2022
Q4 		$1.23M Sell
3,355
-148
-4% -$52.5K 0.38% 58
2022
Q3 		$1.13M Sell
3,503
-1,988
-36% -$630K 0.41% 53
2022
Q2 		$1.78M Sell
5,491
-397
-7% -$119K 0.26% 40
2022
Q1 		$1.69M Sell
5,888
-7,548
-56% -$1.94M 0.18% 58
2021
Q4 		$3.71M Sell
13,436
-198
-1% -$50.2K 0.48% 23
2021
Q3 		$3.15M Buy
13,634
+1
+0% +$247 0.32% 22
2021
Q2 		$3.13M Buy
13,633
+8,180
+150% +$1.64M 0.31% 20
2021
Q1 		$1.02M Buy
5,453
+2,645
+94% +$517K 0.09% 62
2020
Q4 		$474K Sell
2,808
-4,887
-64% -$730K 0.06% 72
2020
Q3 		$1.14M Buy
+7,695
New +$1.19M 0.18% 40
2019
Q2 		– Sell
-100
Closed -$13K – 228
2019
Q1 		$13K Hold
100
– – 0.01% 245
2018
Q4 		$12K Buy
+100
New +$11.2K 0.01% 221

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Lavaca Capital's LLY Position: Q2 2026 in Review

Lavaca Capital increased its Eli Lilly (LLY) stake by 26% in Q2 2026, buying an estimated $102K and bringing the position to 486 shares worth $583K. The position accounts for 0.06% of the portfolio, ranked #74.

Lavaca Capital first reported a position in LLY in Q4 2018 and has held it in 26 quarters since. The position peaked at $3.71M in Q4 2021. 4,599 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Lavaca Capital held 486 shares of Eli Lilly worth $583K as of Q2 2026.
  • Lavaca Capital bought 100 Eli Lilly shares in Q2 2026, an estimated $102K.
  • Eli Lilly made up 0.06% of Lavaca Capital's portfolio in Q2 2026, its #74 holding.
  • Lavaca Capital first reported a position in Eli Lilly in Q4 2018 and has held it in 26 quarters since.
  • Lavaca Capital's Eli Lilly position peaked at $3.71M in Q4 2021.
  • 4,599 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Lavaca Capital's 13F filing for Q2 2026, filed 14 Aug 2026.